Rhinitis/rhinorrhea (Intranasal Products)

DYMISTA (azelastine and fluticasone propionate) nasal spray by Meda

Dymista Granted Expanded Age Range

Meda announced that the Food and Drug Administration (FDA) has approved Dymista (azelastine HCl and fluticasone propionate) for the relief of symptoms of seasonal allergic rhinitis (SAR) in patients ages 6-11 who require treatment with both components.